NCT05236647View on ClinicalTrials.gov

Subcutaneous Versus Intravenous Morphine When Switching From Oral to Parenteral Route in Palliative Cancer Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

March 8, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions

Pain Cancer

Interventions

DRUG

Morphine

Intravenous morphine infusion compared to subcutaneous morphine infusion

Trial Locations (1)

1478

Akershus University Hospital, Lørenskog

All Listed Sponsors

lead

University Hospital, Akershus

OTHER